Everett Hits Rival Acella With 2 Prenatal Patent Suits
New Jersey-based Everett claims in the lawsuits that the prescription prenatal supplements "Choice-OB+DHA" and "PNV-OB with DHA" marketed by Acella are identical copies of — and infringe patents for — supplements marketed by Everett as "Select-OB+DHA" and "Vitafol-OB+DHA."
Because Acella sells its supplements for a lower price, it threatens to cannibalize Everett's market share, the complaints say. Acella's version of the supplement...
To view the full article, register now.